2026 update on EAU Guidelines for Sexual & Reproductive Health

They discuss the latest updates across key sections of the guidelines, including hypogonadism, penile curvature, priapism, and ejaculation disorders. Key changes include the removal of ineffective treatments, updates to conservative management strategies, and the introduction of new options such as hyaluronic acid for Peyronie’s disease.

Their discussion also addresses important considerations in diagnosing hypogonadism, including proper testosterone measurement and distinguishing between functional and organic causes. Challenges related to limited high-quality evidence are emphasised, particularly in areas such as testosterone therapy in prostate cancer survivors and treatment options for ejaculation disorders. Finally, updates to priapism management and treatment algorithms are outlined, reinforcing the importance of balanced, evidence-based recommendations to support clinical decision-making and improve patient care.